Charles River names interim CFO after Pease resignation

Charles River Laboratories International (NYSE: CRL) announced that Chief Financial Officer Flavia H. Pease resigned from her position, effective September 29, 2025, to pursue another opportunity. The company appointed Michael G. Knell, Corporate Senior Vice President and Chief Accounting Officer, as interim CFO until a permanent successor is named.

Pease served as CFO for three years after joining the company. During her tenure, she navigated the company through what CEO James C. Foster described as a challenging demand environment and led cost structure optimization initiatives.

Knell has been with Charles River since 2017 as part of the management team. The company has initiated a search process to identify a permanent CFO replacement.

Charles River reaffirmed its 2025 financial guidance for revenue and non-GAAP earnings per share that was previously announced on August 6, 2025. The company stated this guidance is supported by its current outlook for third-quarter performance.

The Wilmington, Massachusetts-based company provides products and services to pharmaceutical and biotechnology companies, government agencies, and academic institutions for research and drug development efforts.

You May Also Be Interested In

• Hertz cuts guidance, announces notes and stock offerings, shares sink
• CEL-SCI signs distribution deal with Saudi Amarox for cancer drug
• Femasys regains Nasdaq minimum bid price compliance